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Abstract 
 
The industrial solvent trichloroethylene (TCE) has been reported to increase the excretion of 
formic acid in the urine of male Fischer 344 (F-344) rats following large oral doses. We have 
examined the dose-response relationship for formic aciduria in male and female Fischer 344 
rats, the effect of some known metabolites of TCE and examined the response in male Wistar 
rats to help understand its relevance to renal toxicity. We report that doses of TCE as low as 
8mg/kg for 3 days to both male and female F344 rats produced formic aciduria. The formic 
aciduria was time-dependent being more marked after 3 doses compared to one dose in male 
F344 rats and to a lesser extent in female F344 rats. TCE administration to male Wistar rats 
produced less formic aciduria than in male F344 rats, indicating a strain difference in response. 
As TCE is primarily metabolized by cytochrome P450 2E1, Wistar rats were administered 
inducers of cytochrome  P450 2E1 followed by TCE, this increased formic acid excretion to a 
concentration similar to that observed in male F344 rats, indicating a role for P450. 
Administration of the major metabolites of TCE, trichloroethanol and trichloroacetic acid to 
male F344 rats also produced a marked and sustained formic aciduria, while the metabolite of 
TCE formed via glutathione conjugation had no effect on formic acid excretion. The mechanism 
whereby this response occurs is currently not understood, but the formic acid excreted is not a 
metabolite of TCE, but appears to be due to interference with the metabolic utilization of 
formate by a down stream metabolite of TCE. Over the three days of the studies no 
histopathological evidence of kidney toxicity was observed in  F344 rats given TCE, indicating 
that the perturbation of formate metabolism does not lead to acute renal injury.    
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Introduction 
 
Trichloroethylene (TCE) has been used commercially for over 85 years, primarily as a non-
flammable solvent for degreasing metal parts but also as a general purpose solvent (Bakke et al., 
2007). From the 1970’s onward TCE became of environmental concern, due to evaporation 
while handling, chemical processing and leakage from chemical waste sites, leading to its 
contamination of ground water and air (Wu and Schaum, 2000; Ellis and Rivett, 2007; Fan et 
al., 2009). As a consequence, TCE has been detected in the blood of a large number of non-
occupationally exposed adults (Churchill et al., 2001; Blount et al., 2006). Concern was raised 
about  possible long term health effects of TCE and a number of epidemiology studies has 
suggested links between TCE exposure and an increased incidence of tumours at a number of 
sites (Moore et al., 2010; Scott and Chiu, 2006; Scott and Jinot, 2011;Wartenberg et al., 2000). 
In general, these studies have not shown a clear causal relationship between TCE exposure and 
an increased incidence of tumours in humans, although genetic variability in genes involved in 
reductive metabolism of TCE appears to increase the risk of renal cancer (Moore et al., 2010). 
Extensive studies with TCE in experimental animals, has shown that the primary target organs 
for toxicity are the liver and lungs in mice and liver and kidneys in rats. Long term studies have 
shown an increase in tumour incidence in these tissues, see reviews by Bull, (2000); Lock and 
Reed, (2006) and Jollow et al., (2009).  
TCE is primarily metabolised in the liver via cytochrome P450 2E1 (Kim and Ghanayem, 
(2006), and to a lesser extent by other cytochromes P450 (Nakajima et al., 1990), to form an 
unstable epoxide which re-arranges to form chloral. Chloral is then converted to trichloroethanol 
and its glucuronide and trichloroacetic acid (TCA) which are the major metabolites in the urine 
of experimental animals and man (Bloemen et al., 2001; Lash et al., 2000; Lock and Reed, 
2006). A minor pathway of TCE metabolism which seems to operate when the oxidative 
pathway become saturated, is via glutathione conjugation producing the cysteine conjugate S-
(1,2-dichlorovinyl)-L-cysteine (DCVC) which is converted to a reactive metabolite by the 
enzyme cysteine conjugate β-lyase in the kidney (Green et al., 1997; Anders, 2005; Lock and 
Reed, 2006). Liver tumours have been shown to be related to peroxisome proliferation following 
TCE and TCA administration in rats and mice (Bull, 2000), while metabolism via DCVC may 
explain the low incidence of renal tumours in male rats only. Whether enough DCVC is formed 
from TCE in male rats to cause renal injury has been questioned as the amount formed is very 
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small <0.01% of the administered dose (Birner et al., 1993; Bloemen et al., 2001; Green et al., 
1997). More recently it has been proposed that a marked and sustained formic aciduria produced 
by TCE could lead to renal tubule necrosis and regeneration, which may account for the small 
increase in renal cancer (Green et al., 1998). Acute exposure to formic acid has been reported to 
cause renal injury in humans and rats (Jacques, 1982; Liesivuori and Savolainen, 1987).  
Our hypothesis was to examine whether there is indeed a link between formic aciduria and renal 
injury. The work presented in this paper explores the dose-response relationship for TCE-
induced formic aciduria in rats, following acute administration, and the presence of renal injury. 
It also examines whether there is a sex difference in TCE-induced formic aciduria and response 
to TCE metabolites. During the course of these studies we moved from F344 rats to Wistar rats, 
our in-house strain, and discovered they were less responsive with regard to formic acid 
excretion following TCE administration. We have explored this response in limited detail. 
 
 
 
Materials and Methods 
Materials: Deuterium oxide (D2O, 99.9%) from Cambridge Isotope Laboratories, Inc. Andover, 
Massachusetts, USA. Trichloroethylene (TCE), reagent grade, 98%, inhibited with about 1% 1-
2-epoxybutane from Sigma Aldrich, Poole, UK. Pure corn oil, low in saturates and high in 
polyunsaturates from Tesco Supermarket, Liverpool, UK. Protein assay kit, Bio-Rad Detergent 
Compatible from Bio-Rad Laboratories, UK. Li-Heparin, 10ml tubes from Sarstedt, Leicester, 
UK. Quantichrome assay kits for plasma urea and creatinine from Bioassay Systems, Hayward, 
USA. All other chemicals were purchased from Sigma Aldrich, Poole, UK.   
Animals: All animal procedures were performed in accordance with a license issued under the 
UK, Scientific Procedures Act, 1986. Fischer-344 (F344) rats and Wistar-derived rats where 
bred in the Life Science Support Unit at Liverpool John Moores University. The rats were 
housed in plastic cages in a room maintained at 20ºC ± 2ºC and a relative humidity of 50% ± 5% 
with a 12h light-dark cycle starting at 04.00h. Rats were allowed food (rat expanded diet), and 
water ad libitum. F344 male rats (190-240g) and female F344 rats (135-165g) between 7-9 
weeks of age and Wistar-derived male rats (205-253g) were used for these studies, with a 
minimum of 3 rats /group with some studies being done in duplicate or triplicate. 
 
Preparation of dosing solutions: Stock solutions of TCE at 200mg/ml or 3.125mg/ml were 
freshly prepared in corn oil and serially diluted in corn oil to cover doses of 1000 to 32mg/kg 
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and 16 to 2mg/kg respectively. Trichloroethanol (TCE-OH) 3.125mg/ml; perchloroethylene 
(PCE) 3.125mg/ml; carbon tetrachloride (CCl4) 3.125mg/ml and 16mg/ml or chloroform 
(CHCl3) 20mg/ml were prepared in corn oil. Trichloroacetic acid (TCA) was prepared at 
3.125mg/ml in 2mM phosphate buffer neutralised to pH 7.4  and then diluted in buffer to give 
1.56 and 0.78 mg/ml. S-(1,2-dichlorovinyl)-L-cysteine (DCVC) was prepared at 0.4mg/ml in 
2mM phosphate buffer, pH 7.4. All solutions were stored in tightly sealed glass containers, 
wrapped in aluminium foil, at 4°C. For the studies with P 450 inducers, stock solutions of 
pyridine at 100mg/ml; isoniazid at 100mg/ml and phenobarbitone at 80 mg/ml were prepared in 
isotonic saline prior to use. 
 
Treatments:  Rats were placed in metabolic cages for 24h to acclimatise prior to dosing and 
urine collected (Day 0). Urine was collected at 4oC in containers to which was added 0.1ml of 
10% sodium azide to prevent bacterial growth. The major metabolites of TCE, TCA, TCE-OH 
and its glucuronide and formic acid are stable under these conditions (Green et al., 1998).  Rats 
were dosed daily by oral gavage with TCE in corn oil at 5ml/kg/day for 3 days over the dosing 
range of 2-1000mg/kg/day, while controls received corn oil alone at 5ml/kg/day for 3 days (Day 
1, 2 & 3).  
For one study rats were given one dose of TCE at 1000mg/kg (Day 1) followed by corn oil for 2 
days (Day 2 & 3). The rats were returned to the metabolic cages after each dose and urine 
collected over 24h for 3 days (Day 1, 2 & 3) as described above.  
For the studies with TCE metabolites and other halogenated chemicals the rats were dosed by 
oral gavage for 3 days (Day 1, 2 & 3) as follows; TCE-OH, 16mg/kg/day; PCE, 16mg/kg/day; 
CCl4, 16 and 80mg/kg/day; CHCl3, 100mg/kg/day; TCA,  4, 8 and 16mg/kg/day and DCVC, 
2mg/kg/day. Control rats received either corn oil alone or 2mM phosphate buffer, pH 7.4 at 
5ml/kg/day.  
For the studies with cytochrome P450 inducers, male Wistar-derived rats were pretreated with 
either pyridine at 100mg/kg/day ip for 3 days (Kim et al., 1992) or isoniazid at 100mg/kg/day po 
for 4 days (Lake et al., 1998) which induces P450 2E1 or phenobarbitone at 80 mg/kg/day, ip 
for 3 days (Taylor et al., 1985) which induces P450 2B1/2. The rats were placed in metabolic 
cages for 24h after the last dose of inducer (day 0) for urine collection and then dosed with TCE 
at 1000mg/kg/day for 3 days or corn oil alone for 3 days at 5ml/kg/day. The rats were returned 
to the metabolic cages after each dose and urine collected over 24h (Day 1, 2 & 3).  
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Urine analysis & termination: Urine was collected daily for 4 days, kept ice-cold and urine 
volume and pH measured. A sample of urine was taken for 1H-NMR analysis and the remainder 
was frozen at -80°C. After the final urine collection the rats were killed by a rising concentration 
of carbon dioxide and blood collected from the heart into heparinised tubes. The kidneys and 
liver were removed, weighed and a cross section of the kidney, showing the cortex, medulla and 
papilla was fixed in buffered formal saline for histological examination. The remaining kidney 
tissue and liver was stored at -80ºC for subsequent analysis. The blood was centrifuged at 330g 
for 10 min at 4ºC for separation of plasma. The plasma was carefully removed and stored frozen 
at -80ºC for subsequent analysis for creatinine and urea using commercially available assay kits.  
 
Preparation of microsomes and cytochrome P450 assays: Livers from male F344 or male 
Wistar rats dosed with corn oil or the various inducing agents, in the presence or absence of 
TCE were perfused in situ with ice-cold 0.9% saline, rapidly excised, blotted dry, weighed and 
then homogenized (1:4 w/v) in ice-cold buffer (0.154 M KCl, 50mM Tris-HCl, pH 7.4). The 
microsomal fraction was then prepared as described by Taylor et al., (1985) and re-suspended in 
ice-cold storage buffer (0.154M KCl, 10mM HEPES, 1mM EDTA, 20 % (w/v) glycerol, pH 
7.6) and stored in 500ul aliquots at -80°C. 4-Nitrophenol hydroxylase activity indicative of P450 
2E1was measured in liver microsomes by monitoring the increase in the formation of 4-
nitrocatechol from 4-nitrophenol as described by Reinke and Moyer, (1985). Results are 
expressed as nmol 4-nitrocatechol formed min-1 mg protein-1. Protein was measured using a Bio-
Rad protein assay kit using bovine serum albumin as a standard. 
 
Analysis of urine and plasma using 1H-NMR spectroscopy: Aliquots of urine or plasma (500µl) 
were mixed with phosphate buffer (250µl; 0.2M pH 7.4 in D2O). Urine samples contained 
sodium-3(trimethylsilyl) propionate-2,2,3,3-d4 (TSP; 0.5mg TSP/ml buffer) and plasma samples 
maleic acid disodium hydrate (0.5mg/ml buffer) as an internal standard. Samples were 
centrifuged at 14,000g for 10 min at 4ºC and supernatant (600µl)  placed into 5mm NMR tubes 
and 1H-NMR spectra acquired using a Bruker 300MHz  instrument (Bruker Analytik GmbH, 
Germany). The standard ‘noesypr1d’ pulse sequence was utilised for data acquisition on urine, 
which efficiently suppresses the large water signal while the standard pulse sequence 
‘cpmgpr1d’ was utilised for data acquisition on plasma samples. All spectra were baseline 
corrected using Mestrec software and normalised to TSP or maleic acid. Urinary metabolites 
were quantified using the intensity of the resonance with reference to the TSP resonance that 
was set at 0ppm, while plasma metabolites were quantified in the same way with reference to 
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the maleic acid signal at 6ppm. The accuracy of the determination of formic acid was measured 
by spiked addition and found to be 98%. The detection of formic acid using the 3σ method 
(Miller and Miller, 1993) gave an LOD of 0.004mg/ml and using the 10σ method an LOQ of 
0.04mg/ml.  
Histopathology: This was only performed on F344 male rats exposed to 1 or 3 daily doses of 
TCE at 1000mg/kg and 3 daily doses of TCE at 16mg/kg. The portion of kidney fixed in 
buffered formal saline was then dehydrated through a series of alcohols (0-100%v/v) and then 
placed in xylene. The tissue was then embedded in paraffin wax and tissue sections (5µm) cut, 
processed and stained with haematoxylin and eosin. Microscopic examination of the kidney was 
then performed blinded to the treatment by experienced pathologists 
. 
Statistical Analysis: The data are expressed as mean ± standard error of the mean (SEM). 
Significant differences were determined between control and treated groups at each dose or time 
using one-way ANOVA with Bonferroni correction. For the induction studies differences 
between control and treated where determined using a two tailed t-test. Statistical analysis was 
conducted using InStat Graphpad with a p-value < 0.05 considered statistically significant. 
 
 
 
Results 
Urinary excretion of formic acid by male F344 and Wistar rats following 1 or 3 daily oral doses 
of trichloroethylene at 1000mg/kg/day. 
We have examined the concentration of formic acid in urine 1 day before dosing (Day 0) and 
following exposure to 1 or 3 doses of TCE at 1000mg/kg over 3 days (Day 1, 2 & 3). 
Administration of  TCE to male rats, of either strain, as a single dose (Day1) followed by corn 
oil alone (Day 2, 3) or 3 daily doses had no effect on body weight, liver or kidney weights or 
urine volume (data not shown). 1H-NMR analysis of urine showed that the most marked 
difference in the spectra between control (corn oil treated) and TCE-treated rats was the 
appearance of a resonance at 8.44ppm which was attributed to formic acid (compare Figure 1A 
and Figure 1D).  No statistical difference was seen between untreated rats and corn oil treated 
rats with regard to formic acid excretion.  
Following a single dose of TCE, the excretion of formic acid by  F344 rats (Figure 2A) when 
compared to the Wistar rats (Figure 2B), at each time point  was not  statistical different. With 
F344 and Wistar rats given a single dose of TCE formic acid excretion peaked at 2 days and 
 8 
then gradually declined (Figure 2A& 2B).  However, after daily dosing of TCE to F344 rats  the 
formic acid concentration increased after each dose and was statistically significant increased (p 
<0.017 ANOVA)  (Figure 2A), the rats excreting about 60mg over the 3 days. After 3 doses of 
TCE to Wistar rats the formic acid concentration did not increase with time remaining fairly 
constant over the 3 day period (Figure 2B). The major strain difference was related to the total 
amount of formic acid excreted following 3 daily doses of TCE, which in the Wistar rats totalled 
about 10mg, i.e. about 16% of the response seen in F344 rats. In agreement with Green et al., 
(1998), a statistically significant acidification of urine was seen each day after dosing F344 rats 
with daily doses of TCE at 1000mg/kg/day (Figure 2C). After a single dose of TCE at 
1000mg/kg to F344 rats followed by 2 daily doses of corn oil, urinary pH was not significantly 
reduced after dosing TCE (Figure 2C). Acidification of the urine was only seen in Wistar rats 
after 3 doses of TCE (Figure 2D).  
The only other change of note in the 1H-NMR spectra was the appearance of a TCE metabolite,  
TCE-O-glucuronide in the range 3.5-4.6ppm after 1000mg/kg/day which could still be detected 
after 62.5mg/kg/day (Figure 1C&D) but not after 16mg/kg/day (Figure 1B). Small changes in 
individual animals were seen for α-ketoglutarate, citrate and succinate however the mean of all 
animals showed these findings were not statistically significant from corn oil alone treated rats. 
Histopathological examination of the kidneys from F344 rats given TCE at 16mg/kg or 
1000mg/kg daily for 3 days showed no compound related morphological changes. 
 
The effect of induction of cytochrome P450 on trichloroethylene-induced formic aciduria in 
male Wistar rats   
One possible explanation for the marked strain difference in formic aciduria produced after TCE 
administration may be related a strain difference in the activity of hepatic cytochrome(s) P450, 
particularly P450 2E1 (Kim and Ghanayem, 2006),which is the first step in the metabolism of 
TCE. We therefore treated Wistar rats with agents known to induce P450 2E1 (pyridine and 
isoniazid) and P450 2B1/B2 (phenobarbitone) which is also known to metabolise TCE 
(Nakajima et al., 1990) to see if the formic aciduria could be increased to a similar level found 
in F344 rats. Treatment with these various inducers alone, or following TCE, did not increase 
liver to body weight ratio (Table1). The un-induced hepatic activity of 4-nitrophenol 
hydroxylase (P450 2E1) was slightly higher in F344 rats compared to Wistar-derived rats (Table 
1). Prior treatment with pyridine or isoniazid increased hepatic activity of 4-nitrophenol 
hydroxylase (Table 1), and increased formic acid excretion in the urine following TCE 
administration, with isoniazid producing the most marked increase (Table 1). In contrast, prior 
 9 
treatment with phenobarbitone followed by TCE did not increase formic acid excretion when 
compared to TCE administration to naïve rats (Table 1). This indicates that induction of hepatic 
cytochrome P450 2E1 in Wistar-derived rats can increase formic acid excretion following TCE 
exposure. However, our primary objective was to examine the dose-response relationship for 
TCE-induced formic aciduria so for all subsequent studies we used F344 rats. 
 
Dose-response relationship for trichloroethylene-induced formic aciduria in male and female 
F344 rats and plasma levels of formic acid. 
We have examined extent of formic aciduria following TCE administration to female F344 rats 
and looked at much lower doses than previously reported in male F334 rats. To our surprise the 
increase in formic acid in urine in both male and female rats occurred at low doses of TCE, 
down as low as 8mg/kg/day (Figures 3). Thus a 125 -fold decrease in the dose of TCE still 
produced a response, which is well below doses of TCE that are thought to be toxic. In general, 
there was a lot of individual animal variability in the extent of formic acid excreted, some rats 
responding better than others, hence the large standard errors, such that day1 was not 
statistically significant compared to day 0 (Figure 3A & B). However, after 3 doses of TCE 
urinary formic acid excretion of statistically significantly increased compared to day 0 and in 
many cases to day 1(Figure 3A & 3B).There was no sex difference with regard to the dose of 
TCE producing formic aciduria, both sexes responding at 8mg/kg/day, however male F344 rats 
tended to excrete slightly more formic acid than female F344 rats (Figure 3).Although in female 
F344 rats the response was more marked than in Wistar male rats (compare Figure 3B and 
Figure 2B). Urine pH was generally decreased at doses of 16mg/kg/day for 3 days and above in 
male and female rats (data not shown). Evidence of absorption and metabolism was seen by the 
presence of a TCE metabolite, TCE-O-glucuronide in the 1H-NMR spectra of urine at 
1000mg/kg TCE (Figure 1D) but was below the limits of detection by 1H-NMR at 32.5mg/kg 
TCE. Plasma samples taken 24h after the last dose of TCE had elevated concentrations of formic 
acid compared to controls at doses of 8mg/kg/day TCE, and above, in male and female rats 
(Figure 4A &B).  
 
Do trichloroethylene metabolites, perchloroethylene and carbon tetrachloride produce formic 
aciduria in male F344 rats?  
The two major cytochrome P450 dependant metabolites of TCE, trichloroethanol (TCE-OH) and 
trichloroacetic acid (TCA) were able to increase the excretion of formic acid in urine, when 
given at doses likely to be formed from TCE in vivo (Figure 5). Both TCE-OH and TCA at 
 10 
16mg/kg/day after either 1 or 3 doses increased urinary formic acid excretion, while DCVC a 
minor metabolite formed via glutathione conjugation, given at a concentration higher than 
thought to be formed in vivo 2mg/kg/day for 3 days had no effect on formic acid excretion 
(Figure 5). The response with TCA at 16mg/kg/day was very marked being  higher than that 
seen after TCE, however lower doses of 4 and 8 mg/kg/day TCA for 3 days showed little or no 
response (Figure 5) suggesting a steep dose response curve. PCE and carbon tetrachloride at 
16mg/kg/day for 3 days did not increase formic acid excretion in the urine. However, increasing 
the dose of carbon tetrachloride to 80mg/kg/day produced a marked increase in formic acid in 
urine to the levels seen with TCE (Figure 5). Chloroform at a dose of 100mg/kg/day also 
produced a small statistically significant formic aciduria after the third dose (Figure 5). 
 
Discussion 
 We have shown for the first time that formic acid excretion following TCE administration is not 
just a high dose phenomenon but occurs at a dose about 125-fold times lower than the top dose 
used in the cancer bioassay (1000mg/kg/day). Green et al., (1998) reported that treatment of 
male F344 rats with the large doses of TCE produced a marked and sustained formic aciduria 
which is associated with acidification of the urine. Urinary pH falls after TCE treatment by 
about half a pH unit, but no further, this is presumably due to buffering of the urinary pH by 
increased ammonium ion excretion (Liesivuori and Savolainen, 1987; Green et al., 1988). Most 
importantly Green and co-worker’s (1998) showed that the formic acid excreted in the urine of 
TCE-treated rats is not a metabolite of TCE, indicating that it occurs as a result of perturbation 
of endogenous cellular metabolism Following a single dose of TCE the formic aciduria was still 
present 72h after dosing, which is in agreement with Green et al., (1998) who reported it 
reached a maximum by 48h with a half-life of 4-5 days. The consequence of this is that 
following multiple dosing formic aciduria reaches a steady state concentration which is 
maintained for as long as TCE is administered. Green et al., (1998) proposed that a marked and 
sustained excretion of formic acid following TCE administration could lead to renal tubule cell 
injury and repair which could explain the low incidence of renal tumours seen at 500 & 
1000mg/kg/day by gavage and following exposure at 600ppm for 6h/day in male F344 and 
Sprague-Dawley rats (Maltoni et al., 1988; NTP, 1988; 1990). Our findings show that the same 
amount of formic acid is excreted by an oral dose of 16mg/kg/day TCE as by 1000mg/kg/day 
and hence the lower dose would have the same potential to cause renal tubule injury, however it 
unlikely that this is a carcinogenic dose to the male rat kidney, although a bioassay has not been 
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conducted at such low doses. To the best of our knowledge this is the first time a biological 
change has been detected in rats following TCE exposure at such low doses.  
With a number of chlorinated solvents, including TCE, there is often a sex difference observed 
with toxicological responses, male rats being more sensitive than female rats (Lash et al., 2001, 
Pohl et al., 1984, Werner et al., 1995) so it seemed prudent to examine the response of female 
F344 rats to TCE. Similar to male rats, female rats showed a marked and sustained formic 
aciduria which was observed down at doses as low as 8mg/kg/day, the only sex difference was 
related to the amount of formic acid excreted which generally was lower in females, which may 
reflect a lower rate of metabolism in this sex of rat. Associated with the increase in formic acid 
there was an acidification of the urine which was statistically significant at doses of 
62.5mg/kg/day and above. Female rats do not  develop renal tumours after exposure two years 
exposure to TCE (NTP,1988), suggesting that a marked and sustained formic aciduria does not 
cause renal tubule cell injury and repair in female rats, although it is accepted that the amount of 
formic acid excreted is lower compared to male rats.  We found no evidence of renal tubule cell 
injury after three doses of 1000mg/kg/day TCE to male F344 rats, and even after 28 or 90 days 
dosing no renal tubule injury was observed (Green et al., 1998; Lock, unpublished observation) 
clearly any affect of formic acid on the kidney is a result of chronic exposure to a sustained high 
concentration.   
The absorption, metabolism and excretion of TCE in rats have been extensively studied. Prout et 
al., (1985) and Green and Prout, (1985) reported studies in two strains of rat at doses of 10, 500 
and 1000mg/kg when given TCE orally in corn oil. Both strains of rat Osborn-Mendel and 
Wistar handled TCE in a very similar manner, at the high doses a large amount of TCE is 
exhaled unchanged in expired air typically about 50% of the dose (Prout et al., 1985) with 2-4% 
exhaled as CO2.  At 10mg/kg about 1% of the dose was exhaled as unchanged TCE while about 
10% was exhaled as CO2, indicating that metabolism was saturated at the higher doses. The 
main route of excretion of absorbed TCE is via the urine where it is present as TCE-O-
glucuronide and TCA, with 89-91% excreted as TCE-O-glucuronide and 6-8% as TCA over the 
first 24h at 10, 500 and 1000mg/kg (Green and Prout, 1985).  In our studies, we would expect a 
similar pattern of absorption, metabolism and excretion and at the higher doses have detected 
TCE-O-glucuronide in the urine. We have not isolated and purified the glucuronide from urine 
and the 1H-NMR spectra is not available in the literature, our identification is based on our 
experience that the resonance pattern is typical of a glucuronide conjugate.  At low oral doses of 
TCE, (2-16mg/kg) TCE is rapidly absorbed into the blood stream, Lee et al., (2000) reported 
peak blood levels of 0.5µg/ml, 2h after dosing 2mg/kg. In our studies low doses of TCE would 
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be completely absorbed and quite extensively metabolised over 24h to TCA and TCE-O-
glucuronide. Lee and co-workers used an emulsifying solvent to administer TCE which enables 
rapid absorption, while we used corn oil, as in the cancer bioassays, which tends to slow and 
prolong the extent of absorption. Our findings at low doses of TCE may have relevance to TCE 
heavily contaminated drinking water. The only report we are aware that has measured urinary 
formic acid excretion in workers occupationally exposed to TCE is Green et al., (2004). They 
reported that in 70 workers exposed to 25ppm (0.5 to 250ppm) TCE over 4.1 years had a 
statistically significant increase in urinary formic acid excretion: Controls, 5.55 ± 3.0 mg 
formate/g creatinine (54); compared to exposed workers at 9.45 ± 4.78 mg formate/g creatinine 
(70) p< 0.01, suggesting that this response can be observed in humans. We have shown that 
TCE in solution in water given orally to male F344 rats at 8mg/kg/day for 3 days produced a 
marked increase in formic aciduria: controls excreting 1.5mg formic acid/24h while TCE-treated 
excreted 10mg excreted/24h. It seems that doses lower than 8mg.kg/day TCE only produces a 
small formic aciduria in F344 rats. 
 
We discovered by chance, wanting to use our inbred strain of Wistar rats that they excreted less 
formic acid in their urine after TCE exposure than F344 rats.  As TCE is primarily metabolised 
by cytochrome P450 2E1 (Kim and Ghanayem, 2006) we examined the hepatic activity of P450 
2E1, using 4-nitrophenol as substrate and showed that the activity with this substrate was only 
slightly higher in the F344 strain. We examined the effect of inducing P450 2E1 in male Wistar 
rats by pre-treating them with known inducers showed that this did indeed increase the extent of 
formic aciduria after TCE administration to concentrations seen in F344 rats given TCE, 
supporting the view that oxidative metabolism of TCE is required to cause the formic aciduria. 
In contrast, induction of P450 2B1/2 also reported to metabolise TCE did not increase formic 
acid excretion. We are aware that pyridine also increases P450 3A1 and P450 3A2, in addition 
to P450 2E1 (Kim, et al., 2001), so we cannot exclude a role for P450 3A1/A2 in this response. 
However, it was not our aim to understand in detail the basis for the strain difference in response 
to TCE, but our findings indicate that metabolism of TCE by cytochrome P450 is an essential 
step in the production of formic aciduria. 
We also established that the major metabolites of TCE; TCE-OH and TCA both produce a 
marked and sustained increase in formic acid in the urine of male F344 rats at dose likely to be 
formed in vivo from TCE when given at 1000mg/kg (Figure 5). Choral an intermediate 
metabolite following P450  metabolism did not produce a significant increase in formic aciduria 
(Dow and Green, 2000),while the metabolite of the minor glutathione conjugation pathway  
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DCVC, also did not produce this response. A limited dose-response study with TCA showed a 
very marked response at 16mg/kg/day, much greater than that seen with TCE, with only a small 
response at 8mg/kg/day suggesting a very steep dose response curve (Figure 5). So at this stage 
we cannot rule out that a strain difference in the production of TCE-OH and or TCA could 
explain the strain difference in formic aciduria. Interestingly, PCE which like TCE undergoes 
metabolism to generate TCA (Odum et al., 1988) showed little evidence of formic aciduria after 
3 daily doses 16mg/kg (Figure 5). Other chlorinated solvents at higher doses also caused formic 
aciduria, namely carbon tetrachloride and chloroform (Figure 5) and bromdichloromethane 
(Lock et al., 2004). 
  
The mechanism whereby TCE and halomethanes perturb formate metabolism is not understood 
and has not been studied in this manuscript. Currently there are 2 main routes whereby TCE 
could form reactive intermediates. TCE oxide is a reactive electrophile formed during TCE 
oxidation which rearranges to acylating intermediates (Miller and Guengerich, 1982). Mice 
treated with TCE have N(6)-dichloroacetylLys residues in P4502E1 as detected by 
immunochemical methods Cai and Guengerich (2001). Furthermore, Lys adducts were detected 
in the reaction of TCE oxide with both P450 2E1 and NADPH-P450 reductase, with a large 
amount of N(6)-formylLys observed (Cai and Guengerich, 2001). So it is possible that these 
reactive intermediates could disrupt enzymes in pathways utilising formate. Another possibility 
is that carbon tetrachloride is able to produce formic aciduria and is known to undergo reductive 
metabolism by cytochrome P450 to form a trichloromethyl radical (Weber et. al., 2003), 
similarly chloroform can undergo activation to free radical intermediates in vitro and in vivo 
(Tomasi et al., 1985). While TCA has been reported in vitro to form a dichloromethyl radical in 
the presence of rat and mouse liver microsomes (Merdink et al., 2000). Thus there a two 
possible routes of metabolism that could lead to reactive metabolites which could perturb 
biological enzyme activities and potentially lead to formic aciduria. Further studies are needed 
to understand the basis for the perturbation of formate metabolism by TCE metabolites. 
In summary, we have shown that TCE produces an increase in the urinary excretion of formic 
acid in both male and female F344 rats and most importantly that this is not a high dose 
phenomenon, being seen at doses as low as 8mg/kg/day for 3 days. Both TCE-OH and TCA the 
primary metabolites also produce formic aciduria, suggesting it is a cytochrome P450-mediated 
TCE metabolite and not the parent compound that produces the increased formate excretion in 
urine. There is also a marked rat strain difference in TCE-induced formic aciduria, Wistar rats 
 14 
being low responders and F344 rats being higher responders, which could also be related to 
cytochrome P450 metabolism.  
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Figure legends 
 
Figure 1. 1H-NMR spectra of male F344 rat urine after dosing with 16, 62.5 or 1000mg/kg 
trichloroethylene/day for 3 days. 
Male F344 rats were placed in metabolism cages and urine collected for 24h (Day 0) then dosed 
orally with 16, 62.5 or 1000mg/kg/day TCE for 3 days with 24h urine collected on Day 1, 2 and 
3. The urine was then analysed using 1H-NMR spectroscopy with TSP (0.5mg/ml) as reference 
signal at 0ppm. Formic acid appears at 8.44ppm. A, B, C and D show typical spectra from one 
rat in each group on day 3.  
 
Figure 2. Urinary formic acid concentration and pH in male F344 and Wistar rats given 
daily doses of trichloroethylene (1000mg/kg) for one or three days. 
Three groups of male F344 rats (A, C) and male Wistar rats (B, D) were dosed orally with either 
a single dose of TCE (1000mg/kg)(Day1) followed by daily doses of corn oil for 2 days (Days 2 
& 3) or daily doses of TCE (1000mg/kg) for three days (Day1,2 &3). Controls received corn oil 
alone. Urine was collected for 24h before dosing Day 0 and 24h after dosing on Day 1, 2 & 3 the 
urine pH measured and the samples analysed using 1H-NMR spectroscopy. Values are mean ± 
SEM, n =3   
* P<0.05 statistically significantly different from corn oil control (Day 0). 
** P<0.01 statistically significantly different from corn oil control (Day 0). 
 
 
Figure 3. Dose-response relationship for the excretion of formic acid in urine by male (A) 
and female (B) F344 rats following trichloroethylene.  
Male and female F344 rats were placed in metabolism cages and urine collected for 24h (Day 0) 
then dosed orally with either 2, 4, 8, 12, 16, 31, 62.5, 125, 250, 500 or 1000mg/kg/day TCE for 
3 days (Days 1,2 & 3), controls received corn oil alone. Urine was collected on days 1 &3 and 
analysed for formic acid using 1H-NMR spectroscopy. Values are mean ± SEM, n=3-5 except 
for corn oil where n= 8.  
* P<0.05 statistically significantly different from corn oil control (Day 0).  
** P<0.01 statistically significantly different from corn oil control (Day 0).  
*** P<0.001 statistically significantly different from corn oil control (Day0).  
† P<0.05 statistically significantly different from TCE on Day 1. 
††† P<0.001 statistically significantly different from TCE on Day 1. 
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Figure 4. Concentration of formic acid in the plasma of male and female F344 rats 
following 3 daily doses of trichloroethylene. 
 
Male F344 rats (A) were given oral doses of TCE at 2, 4, 8, 16, 31, 62.5, 125, 250, 500 or 
1000mg/kg/day for three days and female F344 rats (B) daily oral doses of TCE at 8, 16 or 
31mg/kg/day for 3 days. Controls received corn oil alone. All rats were killed 24h after the last 
dose, plasma collected and analysed for formic acid using 1H-NMR spectroscopy. Values are 
mean ± SEM, n=3-5. 
* P<0.05 statistically significantly different from corn oil control  
 
Figure 5. The ability of various halogenated chemicals to produce formic aciduria in male 
F344 rats. 
 
Male F344 rats were orally dosed daily for 3 days with of corn oil, trichloroethylene (TCE, 
16mg/kg), trichloroethanol (TCE-OH 16mg/kg), trichloroacetic acid (TCA, 4, 8 or 16 mg/kg), 
S-(1,2,-dichlorovinyl)-L-cysteine, (DCVC, 2mg/kg), perchloroethylene (PCE,16mg/kg), carbon 
tetrachloride (CCl4, 16 or 80mg/kg) or chloroform (CHCl3,100mg/kg). Urine was collected 24h 
before dosing day 0 and after dosing on days 1 and 3. Urine samples were analysed for formic 
acid using 1H-NMR spectroscopy. Values are mean ± SEM, n=3-5. 
* P<0.05 statistically significantly different from corn oil control.  
** P<0.01 statistically significantly different from corn oil control.  
*** P<0.001 statistically significantly different from corn oil control.  
 
 
 
 
 
 
 
 
 
